Education
About Us
Working with TipRanks
Follow Us
Profound Medical (TSE:PRN)
TSX:PRN
Earnings Data
Report Date
May 08, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.4Last Year’s EPS
-0.37Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 06, 2025
|% Change Since: -35.30%
|Next Earnings Date:May 08, 2025
Earnings Call Sentiment|Positive
Overall, the earnings call reflects a positive outlook with significant achievements in revenue growth, improved margins, and a strengthened commercial organization. Despite continued net losses and increased expenses, the company is optimistic about future growth driven by new clinical data, reimbursement improvements, and strategic expansions.Company Guidance
During the Profound Medical Fourth Quarter and Full Year 2024 Financial Results Conference Call, the company reported a record revenue of $4.2 million for Q4 2024, a 108% increase from $2 million in the same period in 2023. The revenue was composed of $2.7 million from recurring revenue and $1.5 million from one-time capital equipment sales. The gross margin improved significantly to 71% from 52% in Q4 2023. Operating expenses rose to $11.3 million from $9.8 million in the previous year, but the net loss was reduced by 45% to $4.9 million or $0.20 per share, compared to $8.9 million or $0.42 per share in Q4 2023. The company ended the year with $54.9 million in cash. Profound Medical anticipates high double-digit growth in 2025 and triple-digit growth starting in 2026, driven by the adoption of its TULSA-PRO technology and strategic commercial initiatives, including the introduction of new AI modules and expanded reimbursement opportunities.Record Fourth Quarter Revenue
Profound Medical achieved record revenue of $4.2 million in Q4 2024, marking a 108% increase from $2 million in the same period of 2023.
Improved Gross Margin
The gross margin for Q4 2024 was 71%, up from 52% in Q4 2023, indicating improved profitability.
Significant Reduction in Net Loss
Net loss in Q4 2024 was $4.9 million, a 45% improvement compared to a net loss of $8.9 million in Q4 2023.
Strong Cash Position
As of December 31, 2024, Profound had cash reserves of $54.9 million, indicating financial stability.
Successful Clinical Trials and Presentations
TULSA-PRO was featured in 17 presentations at major society meetings, showcasing its precision and flexibility in prostate disease treatment.
Expansion of Commercial Organization
A complete turnaround of the commercial organization was achieved with the recruitment of a world-class sales team, aiming for significant growth.
Positive Market and Reimbursement Outlook
With Medicare reimbursement in place, there is confidence in robust growth, with expectations of high double-digit revenue growth in 2025.
---
TSE:PRN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TSE:PRN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 06, 2025 | C$10.34 | C$9.91 | -4.16% |
| Nov 07, 2024 | C$12.35 | C$11.98 | -3.00% |
| Aug 08, 2024 | C$12.89 | C$13.05 | +1.24% |
| May 09, 2024 | C$11.64 | C$10.56 | -9.28% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Profound Medical (TSE:PRN) report earnings?
Profound Medical (TSE:PRN) is schdueled to report earning on May 08, 2025, TBA Not Confirmed.
What is Profound Medical (TSE:PRN) earnings time?
Profound Medical (TSE:PRN) earnings time is at May 08, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:PRN EPS forecast?
TSE:PRN EPS forecast for the fiscal quarter 2025 (Q1) is -0.4.
---